|
Volumn 277, Issue 36, 2002, Pages 32775-32780
|
Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELLS;
DRUG PRODUCTS;
GENES;
TUMORS;
PHOSPHORYLATION;
BIOCHEMISTRY;
2 (2 AMINO 3 METHOXYPHENYL)CHROMONE;
GELATINASE A;
INDOMETACIN;
MITOGEN ACTIVATED PROTEIN KINASE;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
TRANSCRIPTION FACTOR SP1;
TRANSCRIPTION FACTOR SP3;
ARTICLE;
CONTROLLED STUDY;
DRUG MECHANISM;
ENZYME ACTIVITY;
GENETIC TRANSCRIPTION;
HUMAN;
HUMAN CELL;
LUNG CANCER;
PRIORITY JOURNAL;
PROTEIN DNA BINDING;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BINDING SITES;
CELL NUCLEUS;
DNA;
DNA MUTATIONAL ANALYSIS;
FLAVONOIDS;
GENE DELETION;
HUMANS;
IMMUNOBLOTTING;
INDOMETHACIN;
MATRIX METALLOPROTEINASE 2;
MITOGEN-ACTIVATED PROTEIN KINASES;
PHOSPHORYLATION;
PLASMIDS;
PRECIPITIN TESTS;
PROMOTER REGIONS (GENETICS);
PROTEASE INHIBITORS;
SIGNAL TRANSDUCTION;
SP1 TRANSCRIPTION FACTOR;
TIME FACTORS;
TRANSCRIPTION, GENETIC;
TUMOR CELLS, CULTURED;
|
EID: 0037031833
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M202334200 Document Type: Article |
Times cited : (100)
|
References (35)
|